IN THIS ISSUE:
FEATURE: New Drugs in Opiate Addiction Battle.
As the overdose statistics continue to rise the need for innovative ways to deal with the Opiate epidemic. Can new drugs be the answer? A look at three promising advances.
OncoSec Advances IL 12 Immunotherpy for Melanoma
Interpace Reports Year End Results
CymaBay Announces the Retirement of President, CEO, Harold Van Wart, Ph.D.
ITUS closes $4.7 Million Rights offering
Glynn Wilson, CEO of TapImmune on cancer treatment
David Buzkin, head of Marcum’s SEC practice on IPO trends
IDEAS & TECHNOLOGIES:
Sensori AB- Medical Devices for the Human Senses with Common Sense
Genprex- Developing 21st Century Gene Therapies for Cancer
Leap Therapeutics- Developing Antibodies to Treat Cancer
SeaSpine- Most Advanced and Effective Spinal Surgery Technologies Worldwide
Med Industry Associations joins to back MedTech Conference
BioCentury holds 24th Future Leaders Conference
Chinese Pharma Industry Leader Mingde Yu to Keynote Shanghai Conference